SCHEMBL7784100

SCHEMBL7784100

O=c1ccc2c3c(c4occc(=O)c4c2o1)C=CCO3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.40
CYP1A1 P04798 8/20 0.40
CYP1B1 Q16678 7/20 0.40
CYP3A4 P08684 4/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
POLB P06746 1/20 0.35
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
ALDH1A1 P00352 3/20 0.35
ALOX15 P16050 1/20 0.35
KCNA2 P16389 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPT P10636 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4935212 0.81 CYP1A2 (0.50) CYP1A2CYP1A1CYP1B1CA12CA1
SCHEMBL4920144 0.68 CYP1A2 (0.54) CYP1A2CYP1A1CYP1B1KDM4EHPGD
SCHEMBL17237785 0.68
SCHEMBL7875475 0.65 GAA (0.43) CYP1A2CYP1A1CYP1B1CYP3A4KDM4E
SCHEMBL7899553 0.63 CYP1A2 (0.32) CYP1A2CYP1A1CYP1B1
SCHEMBL18579572 0.62 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1KDM4EHPGD
SCHEMBL29207958 0.61 CYP1A2 (0.58) CYP1A2CYP1A1CYP1B1CYP3A4KDM4E
SCHEMBL5940642 0.61 CYP1A2 (0.54) CYP1A2CYP1A1CYP1B1CYP3A4ALDH1A1
SCHEMBL6629828 0.60 CYP1A2 (0.47) CYP1A2CYP1A1CYP1B1CYP3A4MAOA
SCHEMBL4536799 0.58 CYP2B6 (0.47) CYP1A2CYP1A1CYP1B1CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143952-A3 METHOD AND COMPOSITION FOR TREATING AND PREVENTING TUBERCULOSIS Sarawak Medichem Pharmaceuticals Inc. (US) 2002-09-11 EP disclosed
EP-1143952-A2 METHOD AND COMPOSITION FOR TREATING AND PREVENTING TUBERCULOSIS Sarawak Medichem Pharmaceuticals Inc. (US) 2001-10-17 EP disclosed
WO-2000021514-A2 METHOD AND COMPOSITION FOR TREATING AND PREVENTING TUBERCULOSIS SARAWAK MEDICHEM PHARMACEUTICALS, INC. (US) 2000-04-20 WO disclosed